Atypical p-ANCA in PSC and AIH: A hint toward a "leaky gut"?

Clinical Reviews in Allergy and Immunology

Volumn 36, Issue 1, 2009, Pages 40-51

  Terjung, Birgit ^a   Spengler, Ulrich ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Antibodies; Autoimmune disease; Autoimmune hepatitis; Autoimmunity; Infection; Primary sclerosing cholangitis; Regulatory T cells; Toll like receptor

Indexed keywords

ATYPICAL PERINUCLEAR ANTINEUTROPHIL CYTOPLASMIC ANTIBODY; BACTERIAL ANTIGEN; BETA TUBULIN; BETA TUBULIN 5; FTSZ PROTEIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; PATTERN RECOGNITION RECEPTOR; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; CYTOSKELETON PROTEIN; FTSZ PROTEIN, BACTERIA; TOLL LIKE RECEPTOR; TUBULIN; TUBULIN BETAV, HUMAN;

AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; BACTERIAL INFECTION; BRUCELLA; CANDIDA; CHLAMYDIA; CROSS REACTION; CRYPTOSPORIDIUM; CYTOMEGALOVIRUS; DEFENSE MECHANISM; ENTEROCOCCUS; HELICOBACTER; HUMAN; IMMUNE SYSTEM; IMMUNOFLUORESCENCE; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; MICROSPORIDA; MYCOPLASMA PNEUMONIAE; NEUTROPHIL; NONHUMAN; PRIMARY SCLEROSING CHOLANGITIS; REVIEW; TRICHOSPORON; ANIMAL; BACTERIUM; IMMUNOLOGY; INTESTINE; METABOLISM; MICROBIOLOGY; SCLEROSING CHOLANGITIS; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIGENS, BACTERIAL; BACTERIA; BACTERIAL INFECTIONS; BACTERIAL PROTEINS; CHOLANGITIS, SCLEROSING; CROSS REACTIONS; CYTOSKELETAL PROTEINS; HEPATITIS, AUTOIMMUNE; HUMANS; INTESTINES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TUBULIN;

EID: 61949434565     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-008-8088-8     Document Type: Review

References (147)

1. U Broomé A Bergquist 2006 Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer Sem Liver Dis 26 31 41
2. T Griga A Tromm KM Muller B May 2000 Overlap syndrome between autoimmune hepatitis and primary sclerosing cholangitis in two cases Eur J Gastroenterol Hepatol 12 559 564
3. GV Gregorio B Portmann J Karani 2001 Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study Hepatology 33 544 553
4. K Burak P Angulo TM Pasha K Egan J Petz KD Lindor 2004 Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis Am J Gastroenterol 99 523 526
5. K Lazaridis GJ Gores 2006 Primary sclerosing cholangitis and cholangiocarcinoma Sem Liver Dis 26 42 51
6. J Fevery C Verslype G Lai R Aerts W Van Steenbergen 2007 Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis Dig Dis Sci 52 3123 3135
7. T Jess EV Loftus Jr FS Velayos 2007 Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota Am J Gastroenterol 102 829 836
8. RW Boden JG Rankin SJM Goulston W Morrow 1959 The liver in ulcerative colitis; the significance of raised serum-alkaline-phosphatase levels Lancet ii 245 248
9. JG Rankin RW Boden SJM Goulston W Morrow 1959 The liver in ulcerative colitis; treatment of pericholangitis with tetracycline Lancet ii 1110 1112
10. SP Mistilis AP Skrying SJ Goulston 1965 Effect of long-term tetracycline therapy, steroid therapy and colectomy in pericholangitis associated with ulcerative colitis Australas Ann Med 14 286 294
11. IE Vinnik F Kern Jr JE Struthers Jr RB Hill S Guzak 1964 Experimental chronic portal vein bacteremia Proc Soc Exp Biol Med 115 311 314
12. J Ludwig SS Barham NF LaRusso LR Elveback RH Wiesner JT McCall 1981 Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis Hepatology 1 632 640
13. CA Mahony JM Vierling 2006 Etiopathogenesis of primary sclerosing cholangitis Semin Liv Dis 26 3 21
14. EB Martins RW Chapman 2001 Sclerosing cholangitis Curr Opin Gastroenterol 17 458 462
15. MP Manns A Vogel 2006 Autoimmune hepatitis, from mechanisms to therapy Hepatology 43 Suppl. 1 32 144
16. RJ Falk JC Jennette 1988 Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis N Engl J Med 318 1651 1657
17. S Hardarson DR Labrecque FA Mitros GA Neil JA Goeken 1993 Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. High prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis Am J Clin Pathol 99 277 281
18. AHL Mulder G Horst EB Haagsma PC Limburg JH Kleibeuker CGM Kallenberg 1993 Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases Hepatology 17 411 417 (Pubitemid 23072815)
19. AHL Mulder J Broekroelofs G Horst PC Limburg GF Nelis 1994 Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates Clin Exp Immunol 95 490 497
20. S Targan C Landers A Vidrich AJ Czaja 1995 High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis Gastroenterology 108 1159 1166
21. D Bansi R Chapman K Fleming 1996 Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass J Hepatol 24 581 586
22. C Claise C Johanet Y Bouhnik N Kapel JC Homberg R Poupon 1996 Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseases Liver 16 28 34
23. D Zauli S Ghetti A Grassi 1997 Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis Hepatology 25 1105 1107
24. RH Duerr SR Targan CJ Landers 1991 Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis Gastroenterology 100 1385 1391
25. RH Duerr SR Targan CJ Landers 1991 Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses Gastroenterology 100 1590 1596
26. A Wiik 1989 Delineation of a standard procedure for indirect immunofluorescence detection of ANCA APMIS, Acta Pathol Microbiol Immunol Scand 97 suppl.6 12 13
27. J Savige D Gillis E Benson 1999 International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA) Am J Clin Pathol 111 507 513
28. B Terjung V Herzog HJ Worman 1998 Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins Hepatology 28 332 340
29. M Fricker M Hollinshead N White D Vaux 1997 Interphase nuclei of many mammalian cell types contain deep, dynamic, tubular membrane-bound invaginations of the nuclear envelope J Cell Biol 136 531 544
30. B Terjung HJ Worman V Herzog T Sauerbruch U Spengler 2001 Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopy Clin Exp Immunol 126 37 46
31. J Mallolas M Esteve E Rius E Cabré MA Gassull 2000 Antineutrophil antibodies associated with ulcerative colitis interact with the antigen(s) during the process of apoptosis Gut 47 74 78
32. P Billing S Tahir B Calfin 1995 Nuclear localization of the antigen detected by ulcerative colitis-associated perinuclear antineutrophil cytoplasmic antibodies Am J Pathol 147 979 987
33. AJ Czaja GL Norman 2003 Autoantibodies in the diagnosis and management of liver disease J Clin Gastroenterol 37 315 329
34. JW Tervaert FJ van der Woude AS Fauci 1989 Association between active Wegener's granulomatosis and anticytoplasmic antibodies Arch Intern Med 1 2461 2465
35. F Seibold P Weber P Klein PA Berg KH Wiedemann 1992 Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis Gut 33 657 662
36. EB Haagsma AHL Mulder ASH Gouw 1992 Neutrophil cytoplasmic autoantibodies after liver transplantation in patients with primary sclerosing cholangitis J Hepatol 19 8 14
37. C Roozendaal AWM van Milligen de Wit EB Haagsma 1998 Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features Am J Med 105 393 399
38. SK Lo KA Fleming RW Chapman 1994 A 2-year follow-up study of anti-neutrophil antibody in primary sclerosing cholangitis: relationship to clinical activity, liver biochemistry and ursodeoxycholic acid treatment J Hepatol 21 974 978
39. CS Pokorny ID Norton GW McCaughan WS Selby 1994 Anti-neutrophil cytoplasmic antibody: a prognostic indicator in primary sclerosing cholangitis J Gastroenterol Hepatol 9 40 44
40. DE Jenne J Tschopp J Ludemann B Utecht WL Gross 1990 Wegener's autoantigen decoded Nature 346 520
41. MH Zhao CM Lockwood 1996 Azurocidin is a novel antigen for antineutrophil cytoplasmic autoantibodies (ANCA) in systemic vasculitis Clin Exp Immunol 103 397 402
42. MH Zhao SJ Jones CM Lockwood 1995 Bactericidal/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis Clin Exp Immunol 99 49 56
43. MP Stoffel E Csernok C Herzberg T Johnston SF Carroll WL Gross 1996 Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders Clin Exp Immunol 104 54 59
44. RS Walmsley MH Zhao MI Hamilton 1997 Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease Gut 40 105 109
45. S Lindgren S Nilsson L Nassberger 2000 Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease Gastroenterol Hepatol 15 437 442
46. L Halbwachs-Mecarelli P Nusbaum LH Noel 1992 Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis Clin Exp Immunol 90 79 84
47. E Peen S Almer G Bodemar 1993 Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease Gut 34 56 62
48. T Orth R Kellner O Diekmann J Faust KH Meyer zum Büschenfelde WJ Mayet 1998 Identification and characterization of autoantibodies against catalase and alpha-enolase in patients with primary sclerosing cholangitis Clin Exp Immunol 112 507 515
49. C Roozendaal MH Zhao G Horst 1998 Catalase and alpha-enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD) Clin Exp Immunol 112 10 16
50. M Eggena O Cohavy MP Parseghian 2000 Identification of histone H1 as a cognate antigen of the ulcerative colitis-associated marker antibody pANCA J Autoimmun 14 83 97
51. J Sobajima S Ozaki F Osakada 1997 Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2 Clin Exp Immunol 107 135 140
52. J Sobajima S Ozaki H Uesugi 1999 High mobility group (HMG) nonhistone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis Gut 44 867 873
53. B Terjung M Muennich J Gottwein J Soehne 2005 Identification of myeloid-specific tubulin-beta isotype 5 as target antigen of antineutrophil cytoplasmic antibodies in autoimmune liver disorders Hepatology 42 suppl 1 288A
54. SA Lewis ME Gilmartin JL Hall NJ Cowan 1985 Three expressed sequences within the human beta-tubulin multigene family each define a distinct isotype J Mol Biol 182 11 20
55. D Wang A Villasante SA Lewis NJ Cowan 1986 The mammalian beta-tubulin repertoire: hematopoietic expression of a novel, heterologous beta-tubulin isotype J Cell Biol 1034 1903 1910
56. HP Erickson 1995 FtsZ, a prokaryotic homolog of tubulin? Cell 80 367 370
57. CY Ponsioen J Defoer FJ Ten Kate 2002 A survey of infectious agents as risk factors for primary sclerosing cholangitis: are Chlamydia species involved? Eur J Gastroenterol Hepatol 14 641 648
58. O Fausa E Schrumpf K Elgio 1991 Relationship of inflammatory bowel disease and primary sclerosing cholangitis Semin Liver Dis 11 31 39
59. CA Aoki CL Bowlus ME Gershwin 2005 The immunobiology of primary sclerosing cholangitis Autoimmun Rev 4 137 143
60. K Kono K Ohnishi K Omata 1988 Experimental portal fibrosis produced by intraportal injection of killed nonpathogenic Escherichia coli in rabbits Gastroenterology 94 787 796
61. SN Lichtman RB Sartor J Keku JH Schwab 1990 Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth Gastroenterology 98 414 423
62. SN Lichtman EE Okurawa J Keku JH Schwab RB Sartor 1992 Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth J Clin Invest 90 1313 1322
63. ES Bjornsson AF Kilander RG Olsson 2000 Bile duct bacterial isolates in primary sclerosing cholangitis and certain other forms of cholestasis - a study of bile cultures from ERCP Hepatogastroenterology 47 1504 1508
64. SA Patel MC Borges MD Batt HJ Rosenblate 1990 Trichosporon cholangitis associated with hyperbilirubinemia, and findings suggesting primary sclerosing cholangitis on endoscopic retrograde cholangiopancreatography Am J Gastroenterol 85 84 87
65. WZ Mehal AT Hattersley RW Chapman KA Fleming 1992 A survey of cytomegalovirus (CMV) DNA in primary sclerosing cholangitis (PSC) liver tissues using a sensitive polymerase chain reaction (PCR) based assay J Hepatol 15 396 399
66. AA Hamour A Bonnington B Howthorne EGL Wilkins 1993 Successful treatment of AIDS-related cryptosporidial sclerosing cholangitis AIDS 7 1449 1451
67. H Albrecht S Rüsch-Gerdes H-J Stellbrink H Greten S Jäckle 1997 Disseminated Mycobacterium genavense infection as a cause of pseudo-Whipple's disease and sclerosing cholangitis Clin Infect Dis 25 742 743
68. LJ Burgart 1998 Cholangitis in viral disease Mayo Clin Proc 73 479 482
69. M Campos E Huzdani C Sempoux 2000 Sclerosing cholangitis associated to cryptosporidiosis in liver-transplanted children Eur J Pediatr 159 113 115
70. XM Chen NF LaRusso 2002 Cryptosporidiosis and the pathogenesis of AIDS-cholangiopathy Sem Liver Dis 22 277 289
71. MA Selimoglu V Ertekin 2003 Autoimmune hepatitis triggered by Brucella infection or doxycycline or both Int J Clin Pract 57 639 641
72. D Kahana O Cass J Jessurun SJ Schwarzenberg H Sharp K Khan 2003 Sclerosing cholangitis associated with trichosporon infection and natural killer cell deficiency in an 8-year-old girl J Pediatr Gastroenterol Nutr 37 620 623
73. H Kulaksiz G Rudolph P Kloeters-Plachky P Sauer H Geiss A Stiehl 2006 Biliary candida infections in primary sclerosing cholangitis J Hepatol 45 711 716 (Pubitemid 44479874)
74. B Hoffmeister J Ockenga G Schachschal N Suttorp J Seybold 2007 Rapid development of secondary sclerosing cholangitis due to vancomycinresistant enterococci J Infection 54 e65 e68
75. R Olsson E Bjornsson L Backman S Friman K Hockerstedt B Kaijser 1998 Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers J Hepatol 28 426 432
76. JG Fox FE Dewhirst JG Tully 1994 Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice J Clin Microbiol 32 1238 1245
77. JM Ward JG Fox MR Anver 1994 Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species Nat Cancer Inst 86 1222 1227
78. JG Fox X Li L Yan 1996 Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of helicobacter-induced carcinogenesis Infect Immun 64 1548 1558
79. SY Boomkens JG Kusters G Hoffmann 2004 Detection of Helicobacter pylori in bile of cats FEMS Immunol Med Microbiol 42 307 311
80. MT Whary JG Fox 2004 Natural and experimental Helicobacter infections Comp Med 54 128 158
81. TT Lin CT Yeh CS Wu 1995 Detection and partial sequence analysis of Helicobacter pylori DNA in the bile samples Dig Dis Sci 40 2214 2219
82. JG Fox FE Dewhirst Z Shen 1998 Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis Gastroenterology 114 755 763
83. JV Solnick DB Schauer 2001 Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases Clin Microbiol 14 59 97
84. HO Nilsson J Taneera M Castedal E Glatz R Olsson T Wadstrom 2000 Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis J Clin Microbiol 38 1072 1076
85. I Nilsson S Lindgren S Eriksson T Wadstrom 2000 Serum antibodies to Helicobacter hepaticus and Helicobacter pylori in patients with chronic liver disease Gut 46 410 414
86. T Wadström A Ljungh R Willen 2001 Primary biliary cirrhosis and primary sclerosing cholangitis are of infectious origin ! Gut 49 454
87. A Tanaka TP Prindiville R Gish 1999 Are infectious agents involved in primary biliary cirrhosis? A PCR approach J Hepatol 31 664 671
88. HO Nilsson R Mulchandani U Stenram 2001 Helicobacter species identified in liver from patients with cholangiocarcinoma and hepatocellular carcinoma Gastroenterology 120 323 324
89. AM Krasinskas Y Yao P Randhawa MP Dore AR Sepulveda 2007 Helicobacter pylori may play a contributory role in the pathogenesis of primary sclerosing cholangitis Dig Dis Sci 52 2265 2270
90. RW Leong JJ Sung 2002 Review article: Helicobacter species and hepatobiliary diseases Aliment Pharmacol Ther 16 1037 1045
91. JG Fox DB Schauer T Wadström 2001 Curr Opin Gastroenterol 17 S28 S31
92. E Mathai A Arora M Cafferkey CT Keane C M'Morain 1991 The effect of bile acids on the growth and adherence of Helicobacter pylori Aliment Pharmacol Ther 5 653 658
93. TH Magnuson KD Lillemoe BA Zarkin HA Pitt 1992 Patients with uncomplicated cholelithiasis acidify bile normally Dig Dis Sci 37 1517 1522
94. J Rudi A Rudy M Maiwald 1999 Helicobacter sp. are not detectable in bile from German patients with biliary disease Gastroenterology 116 1016 1017
95. M Durazzo R Pellicano A Premoli 2002 Helicobacter pylori seroprevalence in patients with autoimmune hepatitis Dig Dis Sci 47 380 383
96. SY Boomkens S de Rave RG Pot 2005 The role of Helicobacter spp. in the pathogenesis of primary biliary cirrhosis and primary sclerosing cholangitis FEMS Immunol Med Microbiol 44 221 225
97. I Nilsson I Kornilovska S Lindgren A Ljungh T Wadström 2003 Increased prevalence of seropositivity for non-gastric Helicobacter species in patients with autoimmune liver disease J Med Microbiol 52 949 953
98. JM Ward RE Benveniste CH Fox JK Buttles MA Gonda JG Tully 1996 Autoimmunity in chronic active Helicobacter hepatitis of mice. Serum antibodies and expression of heat shock protein 70 in liver Am J Pathos 148 509 517
99. BJ Appelmelk G Faller D Clayes T Kirschner CMJE Van den Brouke-Grauls 1998 Bugs on trial: the case of Helicobacter pylori and autoimmunity Immunol Today 19 296 299
100. CH Hobson TJ Butt DM Ferry J Hunter VS Chadwick MF Broom 1988 Enterohepatic circulation of bacterial chemotactic peptide in rats with experimental colitis Gastroenterology 94 1006 1013
101. S Yamada M Ishii LS Liang T Yamamoto T Toyota 1994 Small duct cholangitis induced by N-formyl L-methionine L-leucine L-tyrosine in rats Gastronenterol 29 631 636
102. O Takeuchi S Sato T Horiuchi 2002 Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins J Immunol 169 10 14
103. K Takeda T Kaisho S Akira 2003 Toll-like receptors Annu Rev Immuno 21 335 376
104. M Li DF Carpio Y Zheng 2001 An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells J Immunol 166 7128 7135
105. D Kyburz J Rethage R Seibl 2003 Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling Arthitis Rheum 48 642 650
106. LA Joosten MI Koenders RL Smeets 2003 Toll-like receptor 2 pathway drives streptococcal cell wall-induced joint inflammation: critical role of myeloid differentiation factor 88 J Immunol 171 6145 6153
107. R Seibl T Birchler S Loeliger 2003 Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium Am J Pathol 162 1221 1227
108. MF Tsan B Gao 2004 Endogenous ligands of Toll-like receptors J Leukoc Biol 76 514 519
109. G Andonegui CS Bonder F Green SC Mullaly L Zbytnuik E Raharjo P Kubes 2003 Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs J Clin Invest 111 1011 1020
110. MG Netea T Radstake LA Joosten JW van der Meer P Barrera BJ Kulberg 2003 Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: association with decreased interferon-gamma production and Toll-like receptor 4 expression Arthitis Rheum 48 1853 1857
111. NC Arbour E Lorenz BC Schutte 2000 TLR4 mutations are associated with endotoxin hyporesponsiveness in humans Nat Genet 25 187 191
112. R Kilding M Akil S Till 2003 A biologically important single nucleotide polymorphism within the toll-like receptor-4 gene is not associated with rheumatoid arthritis Clin Exp Rheumatol 21 340 342
113. C Feterowski K Emmanuilidis T Miethke 2003 Effects of functional Toll-like receptor-4 mutations on the immune response to human and experimental sepsis Immunology 109 426 431
114. L Alexopouloou AC Holt R Medhzitov RA Flavell 2001 Recognition of double-stranded RNA and activation of NF-kappaβ by Toll-like receptor 3 Nature 413 732 738
115. T Wang T Town L Alexopoulou JF Anderson E Fikrig RA Flavell 2004 Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis Nat Med 10 1366 1373
116. H Hemmi T Kaisho O Takeuchi 2002 Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway Nat Immunol 3 196 200
117. AM Krieg AK Yi S Matson 1995 CpG motifs in bacterial DNA trigger direct B-cell activation Nature 374 646 549
118. H Hemmi O Takeuchi T Kawai 2000 A Toll-like receptor recognizes bacterial DNA Nature 408 740 745
119. M Kerkmann LT Costa C Richter 2005 Spontaneous formation of nucleic acid-based nanoparticles is responsible for high interferon-alpha induction by CpG-A in plasmacytoid dendritic cells J Biol Chem 280 8086 8093
120. K Yasuda M Rutz B Schlatter 2006 CpG motif-independent activation of TLR9 upon endosomal translocation of "natural" phosphodiester DNA Eur J Immunol 36 431 436
121. E Latz A Schoenemeyer A Visintin 2004 TLR9 signals after translocating from the ER to CpG DNA in the lysosome Nat Immunol 5 190 198
122. EA Leadbetter IR Rifkin AM Hohlbaum BC Beaudette MJ Sholomchik A Marshak-Rothstein 2002 Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors Nature 416 603 607
123. G Napolitani A Rinaldi F Bertoni F Sallusto A Lanzavecchia 2005 Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells Nat Immunol 6 769 776
124. C Pasare R Medhzitov 2005 Control of B-cell responses by Toll-like receptors Nature 438 364 368
125. GM Deng IM Nilsson M Verdrengh LV Collins A Tarkowski 1999 Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis Nat Med 5 702 705
126. D Fairweather S Frisancho-Kiss NR Rose 2005 Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus-induced myocarditis Rev Med Virol 15 17 27
127. O Kasapcopur Y Ergul S Kutlug C Candan Y Camcioglu N Arisoy 2006 Systemic lupus erythematosus due to Epstein-Barr virus or Epstein-Barr virus infection provocating acute exacerbation of systemic lupus erythematosus? Rheumatol Int 26 765 767
128. M Prinz F Garbe H Schmidt 2006 Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis J Clin Invest 116 456 464
129. A Marshak-Rothstein 2006 Toll-like receptors in systemic autoimmune disease Nat Rev Immunol 6 823 835
130. D Zipris E Lien A Nair 2007 TLR9-signaling pathways are involved in Kilham rat virus-induced autoimmune diabetes in the biobreeding diabetes-resistant rat J Immunol 178 693 701
131. G Liu Y Zhao 2007 Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells Immunology 122 149 156
132. NK Crellin RV Garcia O Hadisfar SE Allan TS Steiner MK Levings 2005 Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells. Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells J Immunol 175 8051 8059
133. RP Sutmuller MH den Brok M Kramer 2006 Toll-like receptor 2 controls expansion and function of regulatory T cells J Clin0 Invest 116 485 494
134. H Liu M Komai-Koma D Xu FY Liew 2006 Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells Proc Natl Acad Sci USA 103 7048 7053
135. AE Gelman J Zhang Y Choi LA Turka 2004 Toll-like receptor ligands directly promote activated CD4+ T cell survival J Immunol 172 6065 6073
136. A Cottalorda C Verschelde A Marcais 2006 TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation Eur J Immunol 36 1684 1693
137. BJ Marsland C Nembrini K Grün 2007 TLR ligands act directly upon T cells to restore proliferation in the absence of protein kinase C-theta signaling and promote autoimmune myocarditis J Immunol 178 3466 3473
138. J Lee JH Mo K Katakura 2006 Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells Nat Cell Biol 8 1327 1336
139. CS Probert AD Christ LJ Saubermann 1997 Analysis of human common bile duct-associated T cells: evidence for oligoclonality, T cell clonal persistence, and epithelial cell recognition J Immunol 158 1941 1948
140. AJ Grant PF Lalor M Salmi S Jalkanen DH Adams 2002 Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease Lancet 359 150 157
141. B Eksteen AJ Grant A Miles 2004 Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis J Exp Med 200 1511 1517
142. AJ Grant PF Lalor SG Hübscher M Briskin DH Adams 2001 MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease) Hepatology 33 1065 1072
143. DH Adams B Eksteen 2006 Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease Nat Rev Immunol 6 244 251
144. R Kuehn J Loehler D Rennick K Rajewsky W Muller 1993 Interleukin-10- deficient mice develop chronic enterocolitis Cell 75 263 274
145. F Seibold S Brandwein S Simpson C Terhorst CO Elson 1998 pANCA represents a cross-reactivity to enteric bacterial antigens J Clin Immunol 18 153 160
146. T Sacher P Knolle T Nichterlein B Arnold GJ Hämmerling A Limmer 2002 CpG-ODN-induced inflammation is sufficient to cause T-cell-mediated autoaggression against hepatocytes Eur J Immunol 32 3628 3637
147. A Radbruch G Muehlinghaus EO Luger 2006 Competence and competition: the challenge of becoming a long-lived plasma cell Nat Rev Immunol 6 741 750